Immunotherapy for Glioblastoma with Adam Sonabend, MD
Рет қаралды 8,276
Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma - the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD, shares promising research on the potential benefits of immunotherapy for certain glioblastoma patients.
@flix4u 2 жыл бұрын
Interesting. I’m 2 days from finishing my 1st round of GBM4 SOC at NW Delnor after 2 surgeries in September & October. I was approved 4 the Proton trial but insurance denied and I tried to fight but ran out of time. I’ll have my first post treatment MRI in 3 weeks. What do I have to do to get connected to this trial?
@roberthortin5357 11 ай бұрын
This is encouraging. I start chemo/radio next week (g4 GBM). No one has mentioned immunotherapy but we have considered trials. Nothing yet. I appreciate your honesty, though, and realise that dedicated ppl are chipping away every day at this insidious disease. 🦘
@susiepolancodemejicanos3554 11 ай бұрын
Mucho ánimo y fe en Dios para sobrellevar el proceso.
Mount Sinai Neurosurgery
Рет қаралды 7 М.
Prostate Cancer Research Institute
Рет қаралды 79 М.
Northwestern Univ. Feinberg School of Medicine
Рет қаралды 226
American Brain Tumor Association
Рет қаралды 3,7 М.
Cure Brain Cancer Foundation
Рет қаралды 15 М.
Seattle Science Foundation
Рет қаралды 7 М.
MaviGadget
Рет қаралды 10 МЛН
Александр Мальков
Рет қаралды 3,2 МЛН
EZ-GLAZ
Рет қаралды 37 МЛН